Evaluation of the Impact of an Amoxicillin and Amoxicillin/Clavulanic Acid Resistant Probiotic on Key Clinical Outcomes in Children Treated With Amoxicillin or Amoxicillin/Clavulanic Acid (PROACRE)
Bacterial Infections
About this trial
This is an interventional treatment trial for Bacterial Infections
Eligibility Criteria
Inclusion Criteria: Children aged between 4-12 years, of either gender, with a bacterial infection and the use of antibiotic therapy with Amoxicillin or Amoxicillin/clavulanic acid under a Physician's prescription. Informed written consent from legal guardian Exclusion Criteria: Use of antibiotics within 3 months prior to enrolment
Sites / Locations
- Liaquat University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Probiotic Bifidobacterium breve PRL2020
Control
Patients in this arm will receive Probiotic Bifidobacterium breve PRL2020 (20 billion CFU) 2 sticks/day for 10 days in addition to the antibiotic Amoxicillin or Amoxicillin/Clavulanic acid.
Patients in this arm will receive only antibiotic Amoxicillin or Amoxicillin/Clavulanic acid.